INTRODUCTION
The hypothalamic-pituitary-gonadal axis can be manipulated in the early neonatal period of rats by the administration of androgens or oestrogens. Adult male rats treated with oestradiol on the first day of life show atrophy of the testes and sexual accessory glands (Kind, Folch, Maqueo et al. 1965 ; Aguilar, Tejero, Vaticón & Fernandez-Galaz, 1984) , impaired maturation of germ cells (Dhar & Setty, 1976; and of Sertoli and Leydig cells (Gaytan, Pinilla, Aguilar et al. 1986; Gaytan & Aguilar, 1987) and decreased serum testosterone concentrations (Frick, Chang & Kind, 1969; Pinilla, Cocconi, Zoppi & Martini, 1989) .
Pituitary secretion of gonadotrophins is strongly reduced shortly after the neonatal injection of oestro¬ gens (Bellido, Gaytan, Aguilar et al. 1985 ; Aguilar, Bellido, Aguilar et al. 1987) . Moreover, oestrogenized males injected with follicle-stimulating hormone (FSH) and luteinizing hormone (LH) between days 1 and 10 of age showed normal testicular weight, sperm¬ atogenesis and testosterone secretion when adult. This has been interpreted as if the effects of oestradiol on testicular development were mainly indirect and medi¬ ated by the inhibition of gonadotrophin secretion Bellido, Pinilla, Aguilar et al. 1990 ).
In order to determine how oestrogen modifies the hypothalamic-pituitary axis in male neonatal develop¬ ment, we have studied, in the present work, the pitui¬ tary responsiveness to acute stimulation with a LHreleasing hormone (LHRH) agonist during the post¬ natal period and the ability of chronic administration of an LHRH agonist to counteract the effect of oestra¬ diol. It has been assumed that high doses of chron¬ ically administered LHRH agonist induce pituitary desensitization and gonadal blockade in adulthood (Sandow, 1983 (Sandow, , 1986 (Haggi & Aoki, 1981 (Greenwood, Hunter & Glover, 1963) . LH and FSH concentrations are expressed using rat-LH-RP-2 and rat-FSH-RP-2 as standards. All samples were measured in duplicate. (Feder & Whalen, 1965; Gorski & Wagner, 1965) . Oestrogens formed inside the neurone after testosterone aromatization are necessary to mas¬ culinize brain structures (Martini, 1978; Gorski, 1990) , but an excess of oestrogens may induce a dedifferentiation process (Döhler & Hancke, 1978 (Toran-Allerand, 1976; Arai & Matsumoto, 1978;  Naftolin, Garcia-Segura, Keeieetal. 1990 ). However, the reproductive impairment observed in male rats treated neonatally with oestradiol seems to be independent of this organizing effect of oestrogen and caused by a temporal decrease in gonadotrophin secretion observed immediately after neonatal oestro¬ genization Bellido et al. 1990 ). Our results show that neonatal oestrogenization affected FSH secretion more than that of LH (Text- fig. 2 ), which agrees with data indicating that testicu¬ lar function is damaged after neonatal inhibition of FSH secretion (Brown-Grant, Fink, Greig & Murray, 1975) , whereas neonatal male rats treated with antiserum to LH have, as adults, both normal sperma¬ togenesis and testicular development (Goldman & 3. -10 -9 -8 -7
LHRH (mol/1) Gorski, 1972) .
The site of oestradiol action in the control of gona¬ dotrophin secretion in males remains unknown.
Results in vitro suggest that oestradiol increases gona¬ dotrophin secretion (Kotsuji, Winters, Attardi et al. 1988 ), a finding which does not agree with the wellknown inhibitory effect of oestradiol in vivo in males of different species (Plant, 1986) . That there may be a central inhibitory effect is supported by the decline in portal blood LHRH after oestradiol administration (Sarkar& Fink, 1980 Kolho & Huhtaniemi, 1989) . However, the fol¬ lowing differences were observed: (1) testosterone plasma levels decreased in adult rats neonatally treated with eostradiol (Frick et al. 1969; Pinilla et al. 1989 ), but not in those treated with LHRH antiserum or antagonist (Bereu et al. 1977; Bereu, 1982; Kolho et al. 1988 ; Kolho & Huhtaniemi, 1989) , (2) sperma¬ togenesis was abolished in oestrogenized males ), reduced in males treated with LHRH antiserum (Bereu et al. 1977) (Bellido et al. 1985) and only retarded in males treated with LHRH antagonist (Kolho et al. 1988 fig. 4 ), whereas no significant increases were observed in plasma gonadotrophin concentra¬ tion (Text- fig. 3 ). Possibly, the total amount of gona¬ dotrophin released by pituitary glands was unable, after its dilution in blood, to increase the serum hormone concentration.
In summary, we conclude that in oestrogenized males the effectiveness of LHRH is reduced during the neonatal period, possibly because of both a reduced endogenous secretion as well as a decrease in pituitary responsiveness, and that this reduction cannot be counteracted by administration of an LHRH agonist.
